74 related articles for article (PubMed ID: 15174563)
1. The expression and prognostic significance of bone morphogenetic protein-2 in patients with malignant fibrous histiocytoma.
Asano N; Yamakazi T; Seto M; Matsumine A; Yoshikawa H; Uchida A
J Bone Joint Surg Br; 2004 May; 86(4):607-12. PubMed ID: 15174563
[TBL] [Abstract][Full Text] [Related]
2. Expression of transforming growth factor beta isoforms and their receptors in malignant fibrous histiocytoma of soft tissues.
Yamamoto T; Akisue T; Marui T; Fujita I; Matsumoto K; Hitora T; Kawamoto T; Nagira K; Nakatani T; Kurosaka M
Clin Cancer Res; 2004 Sep; 10(17):5804-7. PubMed ID: 15355909
[TBL] [Abstract][Full Text] [Related]
3. Malignant fibrous histiocytoma of the extremity.
Salo JC; Lewis JJ; Woodruff JM; Leung DH; Brennan MF
Cancer; 1999 Apr; 85(8):1765-72. PubMed ID: 10223571
[TBL] [Abstract][Full Text] [Related]
4. P-53 positivity and high proliferative index: factors of bad prognosis in malignant fibrous histiocytomas.
Brinck U; Stachura J; Rudzki Z; Kellner S; Hoefer K; Schauer A
In Vivo; 1995; 9(5):475-8. PubMed ID: 8900926
[TBL] [Abstract][Full Text] [Related]
5. Malignant fibrous histiocytoma of the soft tissues of the trunk and extremities.
Pritchard DJ; Reiman HM; Turcotte RE; Ilstrup DM
Clin Orthop Relat Res; 1993 Apr; (289):58-65. PubMed ID: 8386072
[TBL] [Abstract][Full Text] [Related]
6. Treatment results and prognostic factors in patients with malignant fibrous histiocytoma.
Hsu HC; Huang EY; Wang CJ
Acta Oncol; 2004; 43(6):530-5. PubMed ID: 15370609
[TBL] [Abstract][Full Text] [Related]
7. Myxofibrosarcoma (myxoid malignant fibrous histiocytoma) showing cutaneous presentation: report of two cases.
Fujimura T; Okuyama R; Terui T; Okuno K; Masu A; Masu T; Chiba S; Kunii T; Tagami H; Aiba S
J Cutan Pathol; 2005 Aug; 32(7):512-5. PubMed ID: 16008697
[TBL] [Abstract][Full Text] [Related]
8. [Malignant fibrous histiocytoma of soft tissue: description of 10 cases].
Povar J; Franco JM; Muñoz JR; Horndler C; Arazo P; Portoles A; Velilla J; Gutiérrez A
Med Clin (Barc); 1991 Jan; 96(1):6-10. PubMed ID: 1850813
[TBL] [Abstract][Full Text] [Related]
9. Comparative genomic hybridization of malignant fibrous histiocytoma reveals a novel prognostic marker.
Larramendy ML; Tarkkanen M; Blomqvist C; Virolainen M; Wiklund T; Asko-Seljavaara S; Elomaa I; Knuutila S
Am J Pathol; 1997 Oct; 151(4):1153-61. PubMed ID: 9327749
[TBL] [Abstract][Full Text] [Related]
10. Expression of bone morphogenetic protein and its receptors in osteosarcoma and malignant fibrous histiocytoma.
Mehdi R; Shimizu T; Yoshimura Y; Gomyo H; Takaoka K
Jpn J Clin Oncol; 2000 Jun; 30(6):272-5. PubMed ID: 10939432
[TBL] [Abstract][Full Text] [Related]
11. Malignant fibrous histiocytoma and other fibrohistiocytic tumors in pediatric patients: the St. Jude Children's Research Hospital experience.
Daw NC; Billups CA; Pappo AS; Jenkins JJ; Mahmoud HH; Krasin MJ; Rao BN
Cancer; 2003 Jun; 97(11):2839-47. PubMed ID: 12767098
[TBL] [Abstract][Full Text] [Related]
12. Fibrous histiocytoma: benign and malignant variants.
Barsoum MS; Eissa SS; Mansour MA
Ann R Coll Surg Engl; 1979 Mar; 61(2):149-51. PubMed ID: 219749
[TBL] [Abstract][Full Text] [Related]
13. [Malignant angiomatoid fibrous histiocytoma].
Leu HJ; Briner J; Makek M; Odermatt B
Pathologe; 1987 Sep; 8(5):255-60. PubMed ID: 2823246
[No Abstract] [Full Text] [Related]
14. [Malignant fibrous histiocytoma: a clinicopathologic study of 130 cases (author's transl)].
Hashimoto H
Fukuoka Igaku Zasshi; 1979 Oct; 70(10):585-613. PubMed ID: 230139
[No Abstract] [Full Text] [Related]
15. Clinical significance of BMP7 in human colorectal cancer.
Motoyama K; Tanaka F; Kosaka Y; Mimori K; Uetake H; Inoue H; Sugihara K; Mori M
Ann Surg Oncol; 2008 May; 15(5):1530-7. PubMed ID: 18259822
[TBL] [Abstract][Full Text] [Related]
16. Bone morphogenetic protein-6 is a marker of serous acinar cell differentiation in normal and neoplastic human salivary gland.
Heikinheimo KA; Laine MA; Ritvos OV; Voutilainen RJ; Hogan BL; Leivo IV
Cancer Res; 1999 Nov; 59(22):5815-21. PubMed ID: 10582704
[TBL] [Abstract][Full Text] [Related]
17. Prognostic factors in soft tissue leiomyosarcoma of the extremities: a retrospective analysis of 42 cases.
Massi D; Beltrami G; Mela MM; Pertici M; Capanna R; Franchi A
Eur J Surg Oncol; 2004 Jun; 30(5):565-72. PubMed ID: 15135488
[TBL] [Abstract][Full Text] [Related]
18. Dysadherin expression as a significant prognostic factor and as a determinant of histologic features in synovial sarcoma: special reference to its inverse relationship with E-cadherin expression.
Izumi T; Oda Y; Hasegawa T; Nakanishi Y; Kawai A; Sonobe H; Takahira T; Kobayashi C; Yamamoto H; Tamiya S; Hirohashi S; Iwamoto Y; Tsuneyoshi M
Am J Surg Pathol; 2007 Jan; 31(1):85-94. PubMed ID: 17197923
[TBL] [Abstract][Full Text] [Related]
19. Amphiregulin and epidermal growth factor receptor expression in human malignant fibrous histiocytoma of soft tissues.
Yamamoto T; Fujita I; Akisue T; Marui T; Nakatani T; Kawamoto T; Hitora T; Nagira K; Matsumoto K; Kurosaka M
Anticancer Res; 2004; 24(2C):1307-10. PubMed ID: 15154665
[TBL] [Abstract][Full Text] [Related]
20. [Prognosis in patients with malignant fibrous histiocytoma of the soft tissues].
Chobanian NS; Petrovichev NN; Karapetian RM; Dvorova EK
Vopr Onkol; 1988; 34(7):803-8. PubMed ID: 2844021
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
